The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it ...

Loratadine, a widely prescribed second-generation antihistamine, is commonly used to treat allergic conditions such as hay ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous urticaria (CSU). Dupixent for the treatment of COPD has been approved in more than 45 countries ...

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Strategic ...

The following is a summary of “Patient and physician perspectives on disease burden in chronic spontaneous urticaria,” published in the March 2025 issue of Annals of Allergy, Asthma & Immunology by ...

When your skin is red, itchy, and irritated, it could be a rash or it might be hives. We spoke with experts to learn how to tell the difference and the best ways to manage them.

Morgan Stanley has initiated Celldex Therapeutics (NASDAQ:CLDX) at overweight saying that barzolvolimab (barzol), its asset for chronic urticaria (CU), is poised to become a major revenue ...